Related Experiment Videos
[Evaluation of the outpatient treatment of burns in children]
Insights
Outpatient topical burn treatment for children is safe and effective, with few complications. Most pediatric burn patients treated topically experienced good outcomes, with only minor issues like infection or keloids in a small percentage.
Area of Science:
- Pediatric Emergency Medicine
- Dermatology
- Wound Care
Context:
- Outpatient management of pediatric burns and scalds.
- Evaluation of occlusive topical medication in children aged 0-15 years.
- Follow-up at three and twelve months post-treatment.
Purpose:
- To assess the safety and efficacy of outpatient topical burn treatments in children.
- To identify complications associated with occlusive topical medication.
- To evaluate the need for additional therapies in pediatric burn cases.
Summary:
- 183 children received occlusive topical medication for burns and scalds.
- No toxic side effects from topical treatments were observed.
- Local infections were treated with topical aminoglycosides; systemic antibiotics were needed for fever in some cases. Keloids occurred in 6 children, primarily those requiring additional topical therapy for early complications.
Impact:
- Demonstrates the safety of topical burn treatments in pediatric outpatients.
- Highlights the effectiveness of topical aminoglycosides for localized infections.
- Identifies keloid formation as a potential complication, particularly when initial treatment requires modification.
Abstract:
Outpatient treatment of burns and scalds has been evaluated at the Paediatric Emergency Unit of the Children's Hospital in Trieste. 183 children aged 0-15 years were treated by occlusive topical medication; in all cases control after three and twelve months was performed. No toxic symptomatology due to topical medication was observed. In four children local infection was resolved by topical aminoglycosides; in other four cases general antibiotics had to be administered because of isolate fever. Keloids resulted in 6 cases, 5 of them in the group of 32 children in which base treatment had to be integrated with other topical therapy because of early complications.